SIEGAL JONATHAN 4
4 · Vericel Corp · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Vericel (VCEL) Principal Accounting Officer Jonathan Siegal Receives RSUs
What Happened
Jonathan Siegal, Principal Accounting Officer of Vericel Corporation (VCEL), had restricted stock units (RSUs) vest on February 24, 2026. A total of 3,415 RSUs converted to common shares (1,540 shares valued at $38.09 and 1,875 shares valued at $38.25), with a combined fair market value of about $130,377. To satisfy tax withholding, the company withheld 1,365 shares (627 shares at $38.09 = $23,882; 738 shares at $38.25 = $28,229), leaving Siegal with a net issuance of 2,050 shares (net value ≈ $78,266).
Key Details
- Transaction date: February 24, 2026 (reported on Form 4 filed Feb 26, 2026). Filing appears timely.
- Gross vested shares: 3,415 (1,540 @ $38.09; 1,875 @ $38.25). Gross FMV ≈ $130,377.
- Shares withheld for taxes: 1,365 (627 @ $38.09 = $23,882; 738 @ $38.25 = $28,229). Total withheld ≈ $52,111.
- Net shares issued to insider: 2,050 shares (≈ $78,266 net value).
- Footnotes: RSUs were granted previously (Feb 20, 2025 and Feb 22, 2024) and vesting schedules remain for remaining installments; each RSU converts to one share (see F1, F4, F5). Withholding of shares was to satisfy tax obligations (F3). Fair market values cited in the filing: $38.09 and $38.25 (F7, F8).
- Transaction codes: M = exercise/conversion of derivative (RSU conversion to shares); F = shares withheld to cover tax withholding.
Context
- This was not an open-market sale; shares were withheld by the issuer to cover taxes in connection with RSU vesting (a routine administrative step), not a discretionary sale that signals near-term liquidity preference.
- For retail investors, vesting receipts are informative as compensation expense realization but are not the same as a purchase (which can be a more bullish indicator).
Insider Transaction Report
Form 4
Vericel CorpVCEL
SIEGAL JONATHAN
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-02-24+1,540→ 5,337 total - Tax Payment
Common Stock
[F3][F2]2026-02-24$38.09/sh−627$23,882→ 4,710 total - Exercise/Conversion
Common Stock
[F4][F2]2026-02-24+1,875→ 6,585 total - Tax Payment
Common Stock
[F3][F2]2026-02-24$38.25/sh−738$28,229→ 5,847 total - Exercise/Conversion
Restricted Stock Unit
[F5][F7][F1][F6]2026-02-24+1,540→ 4,620 total→ Common Stock (1,540 underlying) - Exercise/Conversion
Restricted Stock Unit
[F5][F8][F4][F6]2026-02-24+1,875→ 3,750 total→ Common Stock (1,875 underlying)
Footnotes (8)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest in annual installments on February 20, 2027, February 20, 2028, and February 20, 2029, respectively.
- [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F3]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
- [F4]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2027, and February 22, 2028, respectively.
- [F5]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- [F6]No expiration date for this type of award.
- [F7]The Fair Market Value of the vested derivative securities is $38.09 per share.
- [F8]The Fair Market Value of the vested derivative securities is $38.25 per share.
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Siegal|2026-02-26